Skip to main content
Photo: hopeneuro.com

Hope Neurology, PLLC

Knoxville, Tennessee

Dedicated MS Practice
17 Active TrialsInfusion CenterSmall Practice
8 MS centers statewide · Ranked #1 in Tennessee for clinical trials

At a glance

Infusion on site
Yes
Clinical trials
17 active
Insurance
United Healthcare Medicare Advantage HMO, United Healthcare Medicare Advantage HMO/POS

What kind of place is this?

AI summary of this centre's website
One Doctor RelationshipResearch FocusedInfusion On-Site

You are stepping into a small, dedicated neurology practice that centers on MS care and infusion treatment. You may appreciate having your neurology visits and infusion services handled in one Knoxville location, along with a patient portal for added convenience.

Facility Profile

Synthesized from this facility's public website and data sources. Not a recommendation or ranking — just a summary to help you orient.
Direct Doctor Access4/5
Support Services2/5
Clinical Trials & Research3/5
Insurance & Navigation Help2/5
Scheduling & Virtual Care3/5

About Hope Neurology, PLLC

AI summary of this centre's website
This practice combines MS care, neurology, and onsite infusion services in one Knoxville location. Its patient portal adds convenience to a small-practice setting.

Hope Neurology, PLLC serves people living with multiple sclerosis in Knoxville with a strong focus on neurology and MS care. The practice offers onsite infusion services, including Ocrevus treatment. It operates as a single-location private practice, which may appeal to patients who want a more personal care setting. You can also use a patient portal for payments and communication support.

Hope Neurology, PLLC is a small, single-location neurology practice in Knoxville that focuses on multiple sclerosis care. You can receive MS care along with infusion services in the same setting, including treatment options such as Ocrevus. It also offers a patient portal and educational content to help you stay informed and involved in your care.

Services & Treatments

What They Treat

multiple sclerosis

How They Treat It

Multiple sclerosis careNeurology careInfusion servicesClinical trialsOcrevus

Research & Clinical Trials

This center is currently involved in 17 clinical trials — ranked #1 in Tennessee for active trials

A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation
Novartis Pharmaceuticals
Closed to new patientsPhase 4
OfatumumabDisease modifying treatment (DMT)
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis
Hoffmann-La Roche
Closed to new patientsPhase 3
Ocrelizumab
A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis
Eli Lilly and Company
Closed to new patientsPhase 2
LY3541860Placebo
A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple Sclerosis (MS)
Hoffmann-La Roche
RecruitingPhase 2
Ocrelizumab Test FormulationOcrelizumab Reference Formulation
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
Hoffmann-La Roche
Closed to new patientsPhase 3
FenebrutinibOcrelizumabPlacebo matched to ocrelizumabPlacebo matched to fenebrutinib
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
Hoffmann-La Roche
Closed to new patientsPhase 3
OcrelizumabOcrelizumabAntihistamineMethylprednisolone
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
Celgene
RecruitingPhase 2
BMS-986368Placebo
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
Sanofi
Closed to new patientsPhase 3
TolebrutinibPlaceboTeriflunomide
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
Amgen
RecruitingPhase 3
Ocrelizumab (US)Ocrelizumab (EU)ABP 692
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
Sanofi
RecruitingPhase 3
FrexalimabTeriflunomidePlacebo infusionPlacebo tabletMRI contrast-enhancing agentsCholestyramineActivated charcoal
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
Sanofi
RecruitingPhase 3
FrexalimabPlaceboMRI contrast-enhancing agents
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Novartis Pharmaceuticals
RecruitingPhase 3
Remibrutinib oral treatmentOcrelizumab
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
Closed to new patientsPhase 3
RemibrutinibTeriflunomide
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Novartis Pharmaceuticals
Closed to new patientsPhase 3
OfatumumabTetanus toxoid (TT) containing vaccine (Td, Tdap)13-valent pneumococcal conjugate vaccine (13-PCV)23-valent pneumococcal polysaccharide vaccine (23-PPV)Seasonal Quadrivalent influenza vaccineKeyhole limpet hemocyanin (KLH) neo-antigen
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
Sanofi
RecruitingPhase 3
FrexalimabFrexalimabMRI contrast-enhancing preparations
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Novartis Pharmaceuticals
Closed to new patientsPhase 3
Ofatumumab approved doseOfatumumab new dose
Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
Hoffmann-La Roche
Closed to new patientsPhase 3
FenebrutinibTeriflunomidePlacebo

Insurance & Access

Contact

2060 Lakeside Centre Way, Knoxville, TN 37922

Insurance & Support

United Healthcare Medicare Advantage HMOUnited Healthcare Medicare Advantage HMO/POS
Patient Portal

FAQs from Hope Neurology, PLLC

Yes. The practice has onsite infusion services, and Ocrevus is listed among the treatments used there.

Hope Neurology, PLLC provides multiple sclerosis care along with broader neurology care. It is designed as a dedicated MS practice in Knoxville.

Yes. A patient portal is available, and it can be used for payments and communication support.

Care is provided in-person at the Knoxville office.

MS Centers Across the U.S.

Click a state to browse its MS treatment centers.

The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play
Call Website